Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Lifecore Biomedical in the last 12 months.

Price Target: n/a

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	1	1	1	1	1	0
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Knight Keybanc	Keybanc	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Sep 4, 2025
Max Smock William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	May 21, 2025
Jacob Johnson Stephens & Co.	Stephens & Co.	Hold Reiterates $6	Hold	Reiterates	$6	-25.93%	Jan 3, 2025
Matthew Hewitt Craig-Hallum	Craig-Hallum	Strong Buy Maintains $8 → $10	Strong Buy	Maintains	$8 → $10	+23.46%	Nov 22, 2024
Jacob Johnson Stephens & Co.	Stephens & Co.	Hold Maintains $5 → $6	Hold	Maintains	$5 → $6	-25.93%	Oct 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

132.47M

Increased by 2.80%

from 128.87M

Revenue Next Year

147.72M

Increased by 11.51%

from 132.47M

EPS This Year

-0.81

from -1.27

EPS Next Year

-0.64

from -0.81

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	May 30, 2021	May 29, 2022	May 28, 2023	May 26, 2024	May 25, 2025	May 25, 2026	May 25, 2027
Revenue	100.87M	111.27M	103.27M	128.26M	128.87M	132.47M	147.72M
Revenue Growth	-36.98%	10.31%	-7.19%	24.20%	0.47%	2.80%	11.51%
EPS	-1.10	-3.97	-3.32	0.33	-1.27	-0.81	-0.64
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	136.7M	153.7M
Avg	132.5M	147.7M
Low	126.6M	139.0M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	6.1%	16.0%
Avg	2.8%	11.5%
Low	-1.7%	4.9%

EPS Forecast

EPS	2026	2027
High	-0.64	-0.45
Avg	-0.81	-0.64
Low	-0.93	-0.83

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.